FolusoNOgunleyeMD

Physician

Dr. Ogunleye is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Dr. Foluso Ogunleye is an oncologist at the Optumcare Cancer Center, in Las Vegas, NV and is affiliated with multiple hospitals in the area, including UMC, Saint Rose Dignity hospitals, Southern Hill Hospital, Mountain View Hospital, Sunrise Hospital, and the Valley Hospitals system. He received his medical degree from University of Benin Faculty of Medicine and has been in practice 16 years. He specializes in hematologic oncology and is experienced in neuro-oncology, amyloidosis, hematologic oncology, breast cancer, and prostate cancer.

Beaumont Health (Royal Oak)Fellowship, Hematology and Medical Oncology, 2014 - 2017
Roger Williams Medical CenterResidency, Internal Medicine, 2005 - 2008
University of Benin Faculty of MedicineClass of 2001

PubMed

47 citations
Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
Mohammed Ibrahim, Siddhartha Yadav, Foluso Ogunleye, Dana Zakalik> ;BMC Cancer. 2018 Feb 13
Unusual Presentation of a Small-Cell Variant of Anaplastic Large-Cell Lymphoma Case: When a Septic Picture Is Not Sepsis
Zhou Yu, Yifan Pang, Linda Wang, Daniel Ezekwudo, Foluso Ogunleye, Susanna Gaikazian, Mark Micale, James Huang, Ann Marie Blenc, Ishmael Jaiyesimi> ;Case Reports in Hematology. 2017 Sep 24
7 citations
Primary Extranodal Diffuse Large B-Cell Lymphoma of the Prostate: A Case Report.
Daniel Ezekwudo, Foluso Ogunleye, Bolanle Gbadamosi, Leann Blankenship, Michael Kinoyan, Daniel J. Krauss, Mitchell Hollander, Kristle Haberichter, Ishmael Jaiyesimi> ;Case Reports in Oncology. 2017 Jan 1
Reply to S.E. Langabeer.
Foluso Ogunleye, James Huang, Mohammed Ibrahim, Emily Allen, Neil Brennan, Zhou Yu, Marianne Terese Huben, Ishmael Jaiyesimi> ;Journal of Oncology Practice. 2017 Feb 14
8 citations
BCR-ABL Testing by Polymerase Chain Reaction in Patients With Neutrophilia: The William Beaumont Hospital Experience and the Case for Rational Laboratory Test Requests.
Foluso Ogunleye, Mohammed Ibrahim, Emily Allen, Neil Brennan, James Huang, Zhou Yu, Marianne Terese Huben, Ishmael Jaiyesimi> ;Journal of Oncology Practice. 2016 Sep 13
Join now to see all

Journal Articles

Ibrutinib as a Bruton's Tyrosine Kinase Inhibitor in the management of Chronic Lymphocytic Lymphoma
Ogunleye Foluso, MD Alexander Glick, MD Michael Stender, MD Ishmael Jaiyesimi, DO, Clinical lymphoma Myeloma and Leukemia
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advance Non-Small Cell Lung Cancer. A paradigm shift in Stage IV NSCLC treatment
Foluso Ogunleye, MD Mohammed Ibrahim, MD Michael Stender, MD Gregory Kalemkeriam, MD Ishmael Jaiyesimi DO, American Journal of Hematology/Oncology, 1/16/2015

Abstracts/Posters

Programmed cell death-1/Programmed cell death ligand-1(PD-1/PD-L1) inhibitors, heralding a new era of immunotherapy in the management of advanced Non-Small Cell Lung C...
Foluso Ogunleye, LeAnn Blankenship, Vanessa Millisor, Joseph Anderson, Ishmael Jaiyesimi, ancer Treatment and Research Communications, Volume 12, 2017, Pages 6-13, ISSN 2468-2942, https://doi.org/10.1016/j.ctarc.2017.05.002., 5/2/2017
Treatment patterns for resected gastric cancer using the National Cancer Database.
Foluso Nelson Ogunleye, Karna Tushar Sura, Leann Blankenship, Daniel Ezekwudo, Bolanle Gbadamosi, Ishmael A. Jaiyesimi, and Peyman Kabolizadeh, Journal of Clinical Oncology 2017 35:15_suppl, 4061-4061, 5/1/2017